These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 26189482)

  • 1. MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.
    Jafri MA; Zaidi SK; Ansari SA; Al-Qahtani MH; Shay JW
    Expert Opin Ther Targets; 2015; 19(12):1705-23. PubMed ID: 26189482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA: A new player in response to therapy for colorectal cancer.
    Sarvizadeh M; Malekshahi ZV; Razi E; Sharifi H; Moussavi N; Taghizadeh M
    J Cell Physiol; 2019 Jun; 234(6):8533-8540. PubMed ID: 30478837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Role of MicroRNAs in Colorectal Cancer].
    Kim SW
    Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.
    Shirafkan N; Mansoori B; Mohammadi A; Shomali N; Ghasbi M; Baradaran B
    Biomed Pharmacother; 2018 Jan; 97():1319-1330. PubMed ID: 29156521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of microRNAs in cancer.
    Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S
    Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in colorectal cancer: small molecules with big functions.
    Xuan Y; Yang H; Zhao L; Lau WB; Lau B; Ren N; Hu Y; Yi T; Zhao X; Zhou S; Wei Y
    Cancer Lett; 2015 May; 360(2):89-105. PubMed ID: 25524553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications.
    Strubberg AM; Madison BB
    Dis Model Mech; 2017 Mar; 10(3):197-214. PubMed ID: 28250048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells.
    Qiu Z; Guo W; Wang Q; Chen Z; Huang S; Zhao F; Yao M; Zhao Y; He X
    Gastroenterology; 2015 Nov; 149(6):1587-1598.e11. PubMed ID: 26248089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
    Yang Y; Du Y; Liu X; Cho WC
    Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
    Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
    Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of microRNAs in 5-FU resistance of colorectal cancer: Possible mechanisms.
    Marjaneh RM; Khazaei M; Ferns GA; Avan A; Aghaee-Bakhtiari SH
    J Cell Physiol; 2019 Mar; 234(3):2306-2316. PubMed ID: 30191973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments.
    To KKW; Fong W; Tong CWS; Wu M; Yan W; Cho WCS
    Expert Opin Drug Discov; 2020 Jan; 15(1):63-83. PubMed ID: 31739699
    [No Abstract]   [Full Text] [Related]  

  • 16. Current Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer.
    Nedaeinia R; Avan A; Ahmadian M; Nia SN; Ranjbar M; Sharifi M; Goli M; Piroozmand A; Nourmohammadi E; Manian M; Ferns GA; Ghayour-Mobarhan M; Salehi R
    J Cell Biochem; 2017 Dec; 118(12):4129-4140. PubMed ID: 28401648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
    Bertoli G; Cava C; Castiglioni I
    Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Methylation in Colorectal Cancer.
    Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
    Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of key miRNAs and related signaling pathways in colorectal tumorigenesis.
    Yin Y; Song M; Gu B; Qi X; Hu Y; Feng Y; Liu H; Zhou L; Bian Z; Zhang J; Zuo X; Huang Z
    Gene; 2016 Mar; 578(2):177-84. PubMed ID: 26692142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.